Medidata Solutions Inc. (NASDAQ:MDSO) EVP Eileen Schloss sold 3,831 shares of the stock in a transaction dated Wednesday, November 16th. The shares were sold at an average price of $56.60, for a total transaction of $216,834.60. Following the completion of the sale, the executive vice president now owns 33,561 shares of the company’s stock, valued at approximately $1,899,552.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Medidata Solutions Inc. (NASDAQ:MDSO) traded down 1.91% on Friday, reaching $54.48. 303,295 shares of the company traded hands. The stock has a market capitalization of $3.04 billion, a price-to-earnings ratio of 124.38 and a beta of 1.49. The stock’s 50-day moving average is $51.72 and its 200-day moving average is $50.02. Medidata Solutions Inc. has a 1-year low of $30.22 and a 1-year high of $57.85.

Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings data on Tuesday, October 25th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.26 by $0.02. Medidata Solutions had a net margin of 5.70% and a return on equity of 10.46%. The firm earned $120.10 million during the quarter, compared to analysts’ expectations of $118.96 million. During the same period in the previous year, the company earned $0.25 earnings per share. The firm’s quarterly revenue was up 16.5% on a year-over-year basis. Equities research analysts expect that Medidata Solutions Inc. will post $1.02 EPS for the current year.

Insider Buying and Selling by Quarter for Medidata Solutions (NASDAQ:MDSO)

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Acrospire Investment Management LLC boosted its position in Medidata Solutions by 90.0% in the third quarter. Acrospire Investment Management LLC now owns 1,900 shares of the company’s stock valued at $106,000 after buying an additional 900 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Medidata Solutions by 13.0% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,978 shares of the company’s stock valued at $110,000 after buying an additional 227 shares during the last quarter. LS Investment Advisors LLC boosted its position in Medidata Solutions by 9.2% in the second quarter. LS Investment Advisors LLC now owns 2,411 shares of the company’s stock valued at $113,000 after buying an additional 203 shares during the last quarter. Pacer Advisors Inc. bought a new position in Medidata Solutions during the third quarter valued at $191,000. Finally, Tower Research Capital LLC TRC boosted its position in Medidata Solutions by 5.3% in the second quarter. Tower Research Capital LLC TRC now owns 3,498 shares of the company’s stock valued at $164,000 after buying an additional 177 shares during the last quarter.

MDSO has been the subject of several analyst reports. Wells Fargo & Co. lowered shares of Medidata Solutions from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 21st. Needham & Company LLC reiterated a “buy” rating and issued a $60.00 price objective (up previously from $55.00) on shares of Medidata Solutions in a research note on Sunday, July 24th. Morgan Stanley reiterated a “buy” rating and issued a $61.00 price objective on shares of Medidata Solutions in a research note on Thursday, August 25th. TheStreet upgraded shares of Medidata Solutions from a “hold” rating to a “buy” rating in a research note on Thursday, August 25th. Finally, Deutsche Bank AG increased their price objective on shares of Medidata Solutions from $56.00 to $58.00 and gave the company a “buy” rating in a research note on Tuesday, September 13th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and nine have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $54.30.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.

5 Day Chart for NASDAQ:MDSO

Receive News & Stock Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related stocks with our FREE daily email newsletter.